Research programme: guanidine derivatives - Lead Discovery Siena
Latest Information Update: 28 Oct 2022
At a glance
- Originator University of Siena
- Developer Lead Discovery Siena
- Class Antibacterials; Guanidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Clostridium difficile infections; Diarrhoea; Irritable bowel syndrome
Highest Development Phases
- No development reported Clostridium difficile infections; Diarrhoea; Irritable bowel syndrome
Most Recent Events
- 28 Oct 2022 No recent reports of development identified for research development in Clostridium-difficile-infections in Italy
- 28 Oct 2022 No recent reports of development identified for research development in Diarrhoea in Italy
- 28 Oct 2022 No recent reports of development identified for research development in Irritable-bowel-syndrome in Italy